BrainCheck user
(Image courtesy of BrainCheck)

BrainCheck’s eponymous mobile neurocognitive test can detect dementia and concussion. But it has a new application: post-COVID brain fog.

Developed by neurologists at Baylor College of Medicine’s Eagleman Laboratory for Perception and Action, BrainCheck carries an FDA Class II Software as a Medical Device (SaMD) designation and can be used on a tablet or laptop in person or remotely, according to the Houston-based startup.

Get the full story on our sister site, Medical Design & Outsourcing.